Technical Analysis for CBPO - China Biologic Products, Inc.

Grade Last Price % Change Price Change
grade A 115.18 -0.14% -0.16
CBPO closed down 0.14 percent on Friday, October 11, 2019, on approximately normal volume.

Earnings due: Nov 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical CBPO trend table...

Date Alert Name Type % Chg
Spinning Top Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Three Weeks Tight Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -0.14%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.14%
Narrow Range Bar Range Contraction -0.14%
Overbought Stochastic Strength -0.14%
Outside Day Range Expansion 0.07%
Overbought Stochastic Strength 0.07%

Older signals for CBPO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human albumin and human immunoglobulin for intravenous injection (IVIG) products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides injection that is used for the treatment of various original and secondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; human tetanus immunoglobulin for the prevention and therapy of tetanus; and placenta polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company's products under development comprise human prothrombin complex concentrate; human hepatitis B immunoglobulin (PH4) for intravenous injection; human fibrinogen; Varicella hyperimmune globulins; and Human IVIG. It distributes its products directly or through distributors. The company is based in Beijing, the People's Republic of China.
Medicine Biopharmaceutical Immunology Antibodies Immune System Tumors Glycoproteins Rabies Hydrocephalus Immunoglobulin Therapy Measles Shock Tetanus Varicella
Is CBPO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 115.955
52 Week Low 60.08
Average Volume 171,976
200-Day Moving Average 92.7431
50-Day Moving Average 104.4668
20-Day Moving Average 112.9035
10-Day Moving Average 114.983
Average True Range 1.6118
ADX 35.36
+DI 31.0733
-DI 14.13
Chandelier Exit (Long, 3 ATRs ) 111.1196
Chandelier Exit (Short, 3 ATRs ) 104.1004
Upper Bollinger Band 122.195
Lower Bollinger Band 103.612
Percent B (%b) 0.62
BandWidth 16.459189
MACD Line 3.34
MACD Signal Line 3.7035
MACD Histogram -0.3635
Fundamentals Value
Market Cap 3.14 Billion
Num Shares 27.2 Million
EPS 3.84
Price-to-Earnings (P/E) Ratio 29.99
Price-to-Sales 6.40
Price-to-Book 4.00
PEG Ratio 1.53
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 116.13
Resistance 3 (R3) 116.09 115.73 115.97
Resistance 2 (R2) 115.73 115.49 115.75 115.91
Resistance 1 (R1) 115.46 115.34 115.60 115.50 115.86
Pivot Point 115.10 115.10 115.17 115.12 115.10
Support 1 (S1) 114.83 114.86 114.97 114.87 114.50
Support 2 (S2) 114.47 114.71 114.49 114.45
Support 3 (S3) 114.20 114.47 114.39
Support 4 (S4) 114.24